130 related articles for article (PubMed ID: 937013)
1. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
Bondesson G; Högberg T; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
[No Abstract] [Full Text] [Related]
2. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
3. Potential hypolipidemic agents. XVI. Synthesis and plasma lipid-lowering properties of alpha-substituted ethyl 4-dibenzofuranyloxyacetates and ethyl 4-chlorophenoxyacetates. A comparative study.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1977; 14(2):137-48. PubMed ID: 906831
[No Abstract] [Full Text] [Related]
4. Potential hypolipidemic agents. XI. Synthesis, plasma lipid-lowering properties and bioavailability of some esters of 2-(4-dibenzofuranoloxy)-2-methylpropionic acid.
Bondesson G; Högberg T; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(4):361-74. PubMed ID: 1199735
[No Abstract] [Full Text] [Related]
5. Potential hypolipidemic agents. XVIII. Synthesis and lipid-lowering properties of 2-(dibenzothiophenoxy)-2-methylpropionates and related compounds.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):337-60. PubMed ID: 747093
[No Abstract] [Full Text] [Related]
6. Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate.
Gronowitz S; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):361-7. PubMed ID: 747094
[No Abstract] [Full Text] [Related]
7. Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1976; 13(1):1-8. PubMed ID: 1258658
[No Abstract] [Full Text] [Related]
8. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
Moody DE; Reddy JK
Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
[No Abstract] [Full Text] [Related]
9. Potential hypolipidemic agents. XX. Synthesis and lipid-lowering properties of annelated thiophenecarboxylic acids.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):368-81. PubMed ID: 747095
[No Abstract] [Full Text] [Related]
10. Potential hypolipidemic agents. XV Synthesis and plasma lipid-lowering properties of derivatives of 2-phenoxy-2-methylpropionic acid.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(5-6):427-38. PubMed ID: 1020658
[No Abstract] [Full Text] [Related]
11. The spontaneously hyperlipidemic old rat as a model for evaluation of hypolipoproteinemic drugs. Effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins.
Gustafsson K; Kiessling H
Z Versuchstierkd; 1982; 24(5-6):262-70. PubMed ID: 7170838
[No Abstract] [Full Text] [Related]
12. Studies on hypolipidemic agents. II. 3-(4-Phenoxybenzoyl)-propionic acid derivatives.
Tomisawa K; Kameo K; Matsunaga T; Saito S; Hosoda K; Asami Y; Sota K
Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2386-94. PubMed ID: 4064197
[No Abstract] [Full Text] [Related]
13. Long hydrocarbon chain ether diols and ether diacids that favorably alter lipid disorders in vivo.
Mueller R; Yang J; Duan C; Pop E; Zhang LH; Huang TB; Denisenko A; Denisko OV; Oniciu DC; Bisgaier CL; Pape ME; Freiman CD; Goetz B; Cramer CT; Hopson KL; Dasseux JL
J Med Chem; 2004 Oct; 47(21):5183-97. PubMed ID: 15456261
[TBL] [Abstract][Full Text] [Related]
14. Hypolipemic activity of clofibrate-related compounds.
Metz G; Specker M
Arzneimittelforschung; 1975 Nov; 25(11):1686-92. PubMed ID: 1243074
[TBL] [Abstract][Full Text] [Related]
15. Potential hypolipidemic agents. XII. Synthesis and plasma lipid-lowering properties of some 3-pyridylmethyl ethers.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(5-6):445-54. PubMed ID: 1217497
[No Abstract] [Full Text] [Related]
16. [Fenofibrate: chemical development and differences with clofibrate (author's transl)].
Boucherle A
Nouv Presse Med; 1980 Dec; 9(49):3721-3. PubMed ID: 7208336
[TBL] [Abstract][Full Text] [Related]
17. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
Ginocchio AV; Metz G
Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
[TBL] [Abstract][Full Text] [Related]
18. Newer hypolipidemic agents.
Kritchevsky D
Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
[No Abstract] [Full Text] [Related]
19. [Amino acid derivatives of 2-(p-chlorophenoxy)-2-methylpropionic acid as compounds with potential antilipemic agents. II. Preparation of methyl esters of N-[2-(p-chlorophenoxy)-2-methylpropionyl] amino acids].
Kwapiszewski W; Borkowski L
Acta Pol Pharm; 1987; 44(2):121-31. PubMed ID: 3434313
[No Abstract] [Full Text] [Related]
20. Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds.
Bondesson G; Hedbom C; Högberg T; Magnusson O; Stjernström NE; Carlson LA
J Med Chem; 1974 Jan; 17(1):108-12. PubMed ID: 4808456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
